CH589645A5 - - Google Patents

Info

Publication number
CH589645A5
CH589645A5 CH1507575A CH1507575A CH589645A5 CH 589645 A5 CH589645 A5 CH 589645A5 CH 1507575 A CH1507575 A CH 1507575A CH 1507575 A CH1507575 A CH 1507575A CH 589645 A5 CH589645 A5 CH 589645A5
Authority
CH
Switzerland
Application number
CH1507575A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH589645A5 publication Critical patent/CH589645A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH1507575A 1971-06-07 1972-06-06 CH589645A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (de) 1971-06-07 1971-06-07 Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze

Publications (1)

Publication Number Publication Date
CH589645A5 true CH589645A5 (de) 1977-07-15

Family

ID=3569889

Family Applications (7)

Application Number Title Priority Date Filing Date
CH1507475A CH589644A5 (de) 1971-06-07 1972-06-06
CH1507575A CH589645A5 (de) 1971-06-07 1972-06-06
CH840072A CH573425A5 (de) 1971-06-07 1972-06-06
CH1507675A CH589646A5 (de) 1971-06-07 1972-06-06
CH1507175A CH583729A5 (de) 1971-06-07 1972-06-06
CH1507375A CH590269A5 (de) 1971-06-07 1972-06-06
CH1507275A CH591475A5 (de) 1971-06-07 1972-06-06

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1507475A CH589644A5 (de) 1971-06-07 1972-06-06

Family Applications After (5)

Application Number Title Priority Date Filing Date
CH840072A CH573425A5 (de) 1971-06-07 1972-06-06
CH1507675A CH589646A5 (de) 1971-06-07 1972-06-06
CH1507175A CH583729A5 (de) 1971-06-07 1972-06-06
CH1507375A CH590269A5 (de) 1971-06-07 1972-06-06
CH1507275A CH591475A5 (de) 1971-06-07 1972-06-06

Country Status (20)

Country Link
AR (7) AR200112A1 (de)
AT (1) AT311956B (de)
AU (1) AU473287B2 (de)
BE (1) BE784475A (de)
BG (1) BG22822A3 (de)
CA (1) CA1011336A (de)
CH (7) CH589644A5 (de)
DD (1) DD101403A5 (de)
DE (1) DE2223751A1 (de)
ES (1) ES403542A1 (de)
FR (1) FR2140492B1 (de)
GB (1) GB1391491A (de)
HU (1) HU165493B (de)
IE (1) IE37812B1 (de)
IL (1) IL39620A (de)
NL (1) NL7207701A (de)
NO (1) NO136841C (de)
SE (1) SE392902B (de)
SU (8) SU453839A3 (de)
ZA (1) ZA723840B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW279864B (de) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
US5607932A (en) * 1994-07-12 1997-03-04 Janssen Pharmaceutica N.V. Heterocyclic derivatives of azolones
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane
WO2004106291A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
WO2004106292A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
RU2497810C1 (ru) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Способ получения n,n-диарилзамещенных 2-трихлорометилимидазолидинов

Also Published As

Publication number Publication date
ZA723840B (en) 1974-02-27
IE37812L (en) 1972-12-07
SU492085A3 (ru) 1975-11-15
AR203017A1 (es) 1975-08-08
CH590269A5 (de) 1977-07-29
AR207109A1 (es) 1976-09-15
SU505358A3 (ru) 1976-02-28
FR2140492A1 (de) 1973-01-19
ES403542A1 (es) 1975-05-01
GB1391491A (en) 1975-04-23
SU503516A3 (ru) 1976-02-15
CH589646A5 (de) 1977-07-15
HU165493B (de) 1974-09-28
NO136841C (no) 1977-11-16
SU493067A3 (ru) 1975-11-25
BE784475A (fr) 1972-12-06
SU509228A3 (ru) 1976-03-30
CA1011336A (en) 1977-05-31
AR205522A1 (es) 1976-05-14
DE2223751A1 (de) 1972-12-28
SU498907A3 (ru) 1976-01-05
NL7207701A (de) 1972-12-11
AU4312972A (en) 1973-12-13
IL39620A0 (en) 1972-08-30
CH589644A5 (de) 1977-07-15
SE392902B (sv) 1977-04-25
AR202904A1 (es) 1975-07-31
SU499806A3 (ru) 1976-01-15
NO136841B (no) 1977-08-08
DD101403A5 (de) 1973-11-05
AT311956B (de) 1973-12-10
AR200139A1 (es) 1974-10-24
CH591475A5 (de) 1977-09-15
BG22822A3 (bg) 1977-04-20
AR202903A1 (es) 1975-07-31
IL39620A (en) 1977-02-28
AR200112A1 (es) 1974-10-24
IE37812B1 (en) 1977-10-26
CH573425A5 (de) 1976-03-15
CH583729A5 (de) 1977-01-14
AU473287B2 (en) 1973-12-13
SU453839A3 (ru) 1974-12-15
FR2140492B1 (de) 1976-03-05

Similar Documents

Publication Publication Date Title
CS156532B2 (de)
FR2124643A5 (de)
BE778498A (de)
DE2156274A1 (de)
HU165493B (de)
CS153120B1 (de)
CS176209B2 (de)
FR2121501A1 (de)
CS168008B2 (de)
FR2124373B1 (de)
FR2126547A5 (de)
FR2094903A5 (de)
FR2124844A6 (de)
FR2125448A1 (de)
FR2125712A5 (de)
FI51159B (de)
FR2121963A5 (de)
CS172962B2 (de)
DE2122550A1 (de)
CS149166B1 (de)
FR2124125A1 (de)
CS156745B1 (de)
CS156224B1 (de)
CS149836B1 (de)
CS149234B1 (de)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased